CMP: 587


Torrent Pharmaceuticals Ltd. manufactures bulk drugs and pharmaceutical formulations. The Company's formulations include cardio-vascular, psychotropic and anti-biotic drugs while its bulk drugs include atenolol, ciprofloxacin and norfloxacin. Torrent Pharmaceuticals has wholly owned subsidiaries in several regulated and less regulated international markets.

Torrent Pharma is a good buy in mid-cap space. Its currently trading at a P/E of 16 with good dividend yields of 1.36% in the last 12 months. Manageable liabilities. Revenues have grown from 883 Crores to 1778 Crores in the last 5 years. Profits have grown from 113 Crores to 290 Crores in the same period. NPM has improved nicely from 13% to 16% over 5 years. Buy for long term gains.